{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T01:03:05Z","timestamp":1786410185977,"version":"build-2736575974"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.482033\/2020-00"],"award-info":[{"award-number":["88887.482033\/2020-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.phrs.2022.106117","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T12:01:40Z","timestamp":1643889700000},"page":"106117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Effects of terpenes in the treatment of visceral leishmaniasis: A systematic review of preclinical evidence"],"prefix":"10.1016","volume":"177","author":[{"given":"Vagner Dias","family":"Raimundo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renner Philipe Rodrigues","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Machado-Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo de Almeida","family":"Marques-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2022.106117_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.talanta.2019.120122","article-title":"A brief review on the strategy of developing SPR-based biosensors for application to the diagnosis of neglected tropical diseases","volume":"205","author":"Souto","year":"2019","journal-title":"Talanta"},{"key":"10.1016\/j.phrs.2022.106117_bib2","article-title":"Immunogenicity of potential CD4+ and CD8+ T cell epitopes derived from the proteome of Leishmania braziliensis","volume":"10","author":"Silva","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.phrs.2022.106117_bib3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host\u2013pathogen interface","volume":"98","author":"Kaye","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.phrs.2022.106117_bib4","doi-asserted-by":"crossref","first-page":"750","DOI":"10.12688\/f1000research.11120.1","article-title":"Leishmaniasis: a review","volume":"6","author":"Torres-Guerrero","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.phrs.2022.106117_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/2603730","article-title":"Cutaneous leishmaniasis: the complexity of host\u2019s effective immune response against a polymorphic parasitic disease","volume":"2019","author":"Gabriel","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.phrs.2022.106117_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008456","article-title":"Fatal progression of experimental visceral leishmaniasis is associated with intestinal parasitism and secondary infection by commensal bacteria, and is delayed by antibiotic prophylaxis","volume":"16","author":"Lewis","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.phrs.2022.106117_bib7","unstructured":"L. Maxfield, J.S. Crane,\u00a0Leishmaniasis, StatPearls, 2021."},{"key":"10.1016\/j.phrs.2022.106117_bib8","unstructured":"WHO, Leishmaniasis, World Health Organization, 2021."},{"key":"10.1016\/j.phrs.2022.106117_bib9","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1016\/j.vaccine.2015.12.071","article-title":"Status of vaccine research and development of vaccines for leishmaniasis","volume":"34","author":"Gillespie","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.phrs.2022.106117_bib10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1590\/S0365-05962007000200002","article-title":"Tratamento da Leishmaniose Tegumentar Americana","volume":"82","author":"Lima","year":"2007","journal-title":". Bras. Dermatol."},{"key":"10.1016\/j.phrs.2022.106117_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105906","article-title":"Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review","volume":"55","author":"Santos","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.phrs.2022.106117_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005635","article-title":"Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh","volume":"11","author":"Rahman","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.phrs.2022.106117_bib13","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1093\/jac\/dks164","article-title":"Translational pharmacokinetic modelling and simulation for the assessment of duration of contraceptive use after treatment with miltefosine","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.phrs.2022.106117_bib14","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.3390\/ijms20225748","article-title":"An overview of drug resistance in protozoal diseases","volume":"20","author":"Capela","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2022.106117_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.joim.2018.04.004","article-title":"Medicinal plants from the Brazilian Amazonian region and their antileishmanial activity: a review","volume":"16","author":"Da Silva","year":"2018","journal-title":"J. Integr. Med."},{"key":"10.1016\/j.phrs.2022.106117_bib16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ffj.1875","article-title":"Factors affecting secondary metabolite production in plants: volatile components and essential oils","volume":"23","author":"Figueiredo","year":"2008","journal-title":"Flavour Fragr. J."},{"key":"10.1016\/j.phrs.2022.106117_bib17","first-page":"362","article-title":"Pharmacology: a handbook for complementary healthcare professionals","author":"Aldred","year":"2009","journal-title":"Pharmacology"},{"key":"10.1016\/j.phrs.2022.106117_bib18","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/DER.0000000000000218","article-title":"Essential oils, part V: peppermint oil, lavender oil, and lemongrass oil","volume":"27","author":"De Groot","year":"2016","journal-title":"Dermatitis"},{"key":"10.1016\/j.phrs.2022.106117_bib19","article-title":"Terpenos, aromas e a qu\u00edmica dos compostos naturais","volume":"39","author":"Felipe","year":"2017","journal-title":"Qu\u00edm. Nov. Esc."},{"key":"10.1016\/j.phrs.2022.106117_bib20","series-title":"Pharmacognosy Fundamentals, Applications and Strategies","first-page":"233","article-title":"Terpenoids","author":"Ludwiczuk","year":"2017"},{"key":"10.1016\/j.phrs.2022.106117_bib21","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3390\/molecules25092014","article-title":"Trypanocidal activity of four sesquiterpene lactones isolated from asteraceae species","volume":"25","author":"Elso","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2022.106117_bib22","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3390\/molecules24071209","article-title":"Activity of estafietin and analogues on Trypanosoma cruzi and Leishmania braziliensis","volume":"24","author":"S\u00fclsen","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2022.106117_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejmech.2018.07.076","article-title":"Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus","volume":"157","author":"Nuutinen","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2022.106117_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.phymed.2018.10.028","article-title":"Terpenes as possible drugs for the mitigation of arthritic symptoms \u2013 a systematic review","volume":"57","author":"Carvalho","year":"2019","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.phrs.2022.106117_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"41","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"issue":"2019","key":"10.1016\/j.phrs.2022.106117_bib26","article-title":"Plant extracts in the bone repair process: a systematic review","author":"Miranda","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.phrs.2022.106117_bib27","first-page":"1","article-title":"Borneol for regulating the permeability of the blood-brain barrier in experimental ischemic stroke: preclinical evidence and possible mechanism","volume":"2019","author":"Chen","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"14","key":"10.1016\/j.phrs.2022.106117_bib28","first-page":"1","article-title":"SYRCLE\u2019s risk of bias tool for animal studies","volume":"141","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.phrs.2022.106117_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013182","article-title":"Effects of motivational methods on oral hygiene of orthodontic patients: a systematic review and meta-analysis","volume":"97","author":"Huang","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.phrs.2022.106117_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3923\/pjbs.2018.1.7","article-title":"Use of plant extracts in alternative medicine","volume":"21","author":"\u00d6zaslan","year":"2018","journal-title":"Pak. J. Biol. Sci."},{"key":"10.1016\/j.phrs.2022.106117_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jep.2007.08.010","article-title":"Ethnopharmacological approaches to wound healing\u2014exploring medicinal plants of India","volume":"114","author":"Kumar","year":"2007","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2022.106117_bib32","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.3390\/su11195483","article-title":"Asian medicinal plants\u2019 production and utilization potentials: a review","volume":"11","author":"Astutik","year":"2019","journal-title":"Sustainability"},{"key":"10.1016\/j.phrs.2022.106117_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12768","article-title":"Hamster, a close model for visceral leishmaniasis: opportunities and challenges","volume":"42","author":"Saini","year":"2020","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.phrs.2022.106117_bib34","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/jac\/dkr575","article-title":"Asiaticoside induces tumour-necrosis-factor-\u03b1-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains","volume":"67","author":"Bhaumik","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.phrs.2022.106117_bib35","first-page":"251","article-title":"Immunobiology of visceral leishmaniasis","volume":"0","author":"Nyl\u00e9n","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2022.106117_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4103819","article-title":"Sex-related differences in immune response and symptomatic manifestations to infection with Leishmania species","volume":"2019","author":"Lockard","year":"2019","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.phrs.2022.106117_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.exger.2018.01.022","article-title":"Could age and aging change the host response to systemic parasitic infections? A systematic review of preclinical evidence","volume":"104","author":"Felizardo","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.phrs.2022.106117_bib38","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41929-018-0115-4","article-title":"Sesquiterpene cyclisations catalysed inside the resorcinarene capsule and application in the short synthesis of isolongifolene and isolongifolenone","volume":"1","author":"Zhang","year":"2018","journal-title":"Nat. Catal."},{"key":"10.1016\/j.phrs.2022.106117_bib39","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/B978-0-444-64179-3.00007-4","article-title":"Terpenoids as emerging therapeutic agents: cellular targets and mechanisms of action against protozoan parasites","volume":"59","author":"Isah","year":"2018","journal-title":"Stud. Nat. Prod. Chem."},{"issue":"45","key":"10.1016\/j.phrs.2022.106117_bib40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s11745-010-3407-2","article-title":"Molecular dynamics and partitioning of di- tert -butyl nitroxide in stratum corneum membranes: effect of terpenes","volume":"455","author":"Camargos","year":"2010","journal-title":"Lipids"},{"key":"10.1016\/j.phrs.2022.106117_bib41","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3390\/molecules24112072","article-title":"In vitro and in vivo effectiveness of carvacrol, thymol and linalool against Leishmania infantum","volume":"24","author":"Youssefi","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2022.106117_bib42","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ijantimicag.2008.01.028","article-title":"In vitro activity of terpenes against Candida biofilms","volume":"31","author":"Dalleau","year":"2008","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.phrs.2022.106117_bib43","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/2231-4040.104712","article-title":"Terpenes: effect of lipophilicity in enhancing transdermal delivery of alfuzosin hydrochloride","volume":"3","author":"Prasanthi","year":"2012","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.phrs.2022.106117_bib44","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.phymed.2011.03.008","article-title":"Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle","volume":"18","author":"Zore","year":"2011","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2022.106117_bib45","doi-asserted-by":"crossref","first-page":"6250","DOI":"10.1016\/j.bmc.2014.08.020","article-title":"Thymol and eugenol derivatives as potential antileishmanial agents","volume":"22","author":"De Morais","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.phrs.2022.106117_bib46","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1021\/np5008697","article-title":"(-)-\u03b1-Bisabolol, a promising oral compound for the treatment of visceral leishmaniasis","volume":"78","author":"Corpas-L\u00f3pez","year":"2015","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phrs.2022.106117_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/10611860600649765","article-title":"Critical evaluation of the therapeutic potential of bassic acid incorporated in oil-in-water microemulsions and poly-D,L-lactide nanoparticles against experimental leishmaniasis","volume":"14","author":"Lala","year":"2006","journal-title":"J. Drug Target."},{"key":"10.1016\/j.phrs.2022.106117_bib48","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ijantimicag.2017.04.022","article-title":"Antileishmanial and immunomodulatory activities of lupeol, a triterpene compound isolated from Sterculia villosa","volume":"50","author":"Das","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.phrs.2022.106117_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijantimicag.2010.03.008","article-title":"Efficacy of artemisinin in experimental visceral leishmaniasis","volume":"36","author":"Sen","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.phrs.2022.106117_bib50","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.exppara.2007.02.018","article-title":"Leishmania panamensis: comparative inhibition of nuclear DNA topoisomerase II enzymes from promastigotes and human macrophages reveals anti-parasite selectivity of fluoroquinolones, flavonoids and pentamidine","volume":"116","author":"Cort\u00e1zar","year":"2007","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.phrs.2022.106117_bib51","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/jac\/44.6.791","article-title":"Evaluation of the in-vivo activity and toxicity of amarogentin, an antileishmanial agent, in both liposomal and niosomal forms","volume":"44","author":"Medda","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.phrs.2022.106117_bib52","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF03402104","article-title":"Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in antileishmanial therapy","volume":"9","author":"Chowdhury","year":"2003","journal-title":"Mol. Med."},{"key":"10.1016\/j.phrs.2022.106117_bib53","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1476-5381.2009.00609.x","article-title":"16 Alpha-hydroxycleroda-3,13 (14)Z-dien-15,16-olide from Polyalthia longifolia: a safe and orally active antileishmanial agent","volume":"159","author":"Misra","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106117_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1021\/np960018g","article-title":"Amarogentin, a naturally occurring secoiridoid glycoside and a newly recognized inhibitor of topoisomerase I from Leishmania donovani","volume":"59","author":"Ray","year":"1996","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phrs.2022.106117_bib55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13071-016-1412-x","article-title":"Regulation of immunity during visceral Leishmania infection","volume":"9","author":"Rodrigues","year":"2016","journal-title":"Parasit. Vectors"},{"key":"10.1016\/j.phrs.2022.106117_bib56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.micinf.2017.10.009","article-title":"Immunomodulation of dual specificity phosphatase 4 during visceral leishmaniasis","volume":"20","author":"Parveen","year":"2018","journal-title":"Microbes Infect."},{"key":"10.1016\/j.phrs.2022.106117_bib57","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1128\/IAI.00729-15","article-title":"Glycyrrhizic acid-mediated subdual of myeloid-derived suppressor cells induces antileishmanial immune responses in a susceptible host","volume":"83","author":"Bandyopadhyay","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.phrs.2022.106117_bib58","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.4049\/jimmunol.175.2.1161","article-title":"18 Beta-glycyrrhetinic acid triggers curative Th1 response and nitric oxide up-regulation in experimental visceral leishmaniasis associated with the activation of NF-kappa B","volume":"175","author":"Ukil","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2022.106117_bib59","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijantimicag.2014.10.023","article-title":"Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis","volume":"45","author":"Bhattacharjee","year":"2015","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.phrs.2022.106117_bib60","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3390\/molecules25061394","article-title":"Evaluating the potential of ursolic acid as bioproduct for cutaneous and visceral leishmaniasis","volume":"25","author":"Bilbao-Ramos","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2022.106117_bib61","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.2147\/IJN.S106548","article-title":"Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis","volume":"12","author":"Want","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phrs.2022.106117_bib62","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","article-title":"The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response","volume":"166","author":"Melby","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2022.106117_bib63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.niox.2021.04.008","article-title":"Nitric-oxide releasing chitosan nanoparticles towards effective treatment of cutaneous leishmaniasis","volume":"113\u2013114","author":"Cabral","year":"2021","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.phrs.2022.106117_bib64","first-page":"238","article-title":"Immune response to Leishmania infection","volume":"119","author":"Awasthi","year":"2004","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.phrs.2022.106117_bib65","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1128\/IAI.00812-09","article-title":"Comparative study of the ability of Leishmania mexicana promastigotes and amastigotes to alter macrophage signaling and functions","volume":"78","author":"Abu-Dayyeh","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.phrs.2022.106117_bib66","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.1128\/IAI.00853-05","article-title":"Role of host protein tyrosine phosphatase SHP-1 in Leishmania donovani-induced inhibition of nitric oxide production","volume":"74","author":"Forget","year":"2006","journal-title":"Infect. Immun."},{"key":"10.1016\/j.phrs.2022.106117_bib67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cellimm.2016.07.013","article-title":"Leishmania exosomes and other virulence factors: Impact on innate immune response and macrophage functions","volume":"309","author":"Atayde","year":"2016","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.phrs.2022.106117_bib68","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1017\/S0031182019000659","article-title":"Lupeol induces immunity and protective efficacy in a murine model against visceral leishmaniasis","volume":"146","author":"Kaur","year":"2019","journal-title":"Parasitology"},{"key":"10.1016\/j.phrs.2022.106117_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029062","article-title":"Curative effect of 18\u03b2-glycyrrhetinic acid in experimental visceral leishmaniasis depends on phosphatase-dependent modulation of cellular MAP kinases","volume":"6","author":"Ukil","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2022.106117_bib70","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejps.2017.03.046","article-title":"Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes","volume":"104","author":"Kar","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2022.106117_bib71","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/jac\/dks159","article-title":"Glycyrrhizic acid suppresses Cox-2-mediated anti-inflammatory responses during Leishmania donovani infection","volume":"67","author":"Bhattacharjee","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.phrs.2022.106117_bib72","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1128\/IAI.00528-16","article-title":"Leishmania donovani-induced prostaglandin E2 generation is critically dependent on host toll-like receptor 2\u2013cytosolic phospholipase A2 signaling","volume":"84","author":"Bhattacharjee","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.phrs.2022.106117_bib73","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.phymed.2015.08.012","article-title":"Antileishmanial activity and trypanothione reductase effects of terpenes from the Amazonian species Croton cajucara Benth (Euphorbiaceae)","volume":"22","author":"Lima","year":"2015","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phrs.2022.106117_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105158","article-title":"Limonene-carvacrol: a combination of monoterpenes with enhanced antileishmanial activity","volume":"74","author":"Carvalho","year":"2021","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.phrs.2022.106117_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115743","article-title":"Crystal structure of Leishmania mexicana cysteine protease B in complex with a high-affinity azadipeptide nitrile inhibitor","volume":"28","author":"Ribeiro","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.phrs.2022.106117_bib76","doi-asserted-by":"crossref","first-page":"8685","DOI":"10.1021\/jo060295k","article-title":"Sulfated meroterpenoids from the Brazilian Sponge Callyspongia sp. are inhibitors of the antileishmaniasis target adenosine phosphoribosyl transferase","volume":"71","author":"Gray","year":"2006","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.phrs.2022.106117_bib77","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1574-6968.1999.tb13693.x","article-title":"Effect of the microtubule stabilising agent taxol on leishmanial protozoan parasites in vitro","volume":"176","author":"Kapoor","year":"1999","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.phrs.2022.106117_bib78","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1128\/AAC.02459-14","article-title":"Induction of mitochondrial dysfunction and oxidative stress in Leishmania donovani by orally active clerodane diterpene","volume":"58","author":"Kathuria","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phrs.2022.106117_bib79","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/163404","article-title":"Natural sesquiterpene lactones induce oxidative stress in Leishmania mexicana","volume":"2013","author":"Barrera","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.phrs.2022.106117_bib80","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1016\/j.bmcl.2012.09.024","article-title":"Chemotherapy of leishmaniasis. Part XI: synthesis and bioevaluation of novel isoxazole containing heteroretinoid and its amide derivatives","volume":"22","author":"Suryawanshi","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.phrs.2022.106117_bib81","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1038\/s41598-019-44630-4","article-title":"Vitamins (A&D) and Isoprenoid (Chenodeoxycholic acid) molecules are accompanied by Th1 immunostimulatory response and therapeutic cure in vivo: possible antileishmanial drugs","volume":"9","author":"Gogulamudi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2022.106117_bib82","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ijbiomac.2016.09.014","article-title":"Oleanolic acid loaded poly lactic co- glycolic acid- vitamin E TPGS nanoparticles for the treatment of Leishmania donovani infected visceral leishmaniasis","volume":"93","author":"Ghosh","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2022.106117_bib83","first-page":"55","article-title":"Bacopasaponin C: critical evaluation of anti-leishmanial properties in various delivery modes","volume":"9","author":"Sinha","year":"2002","journal-title":"Drug Deliv. J. Deliv. Target. Ther. Agents"},{"key":"10.1016\/j.phrs.2022.106117_bib84","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1021\/jm031150y","article-title":"In vitro and in vivo anti-leishmanial activity of triterpenoid saponins isolated from Maesa balansae and some chemical derivatives","volume":"48","author":"Germonprez","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.phrs.2022.106117_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpddr.2016.12.002","article-title":"Therapeutic effect of ursolic acid in experimental visceral leishmaniasis","volume":"7","author":"Jesus","year":"2017","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.phrs.2022.106117_bib86","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fimmu.2016.00153","article-title":"The contribution of immune evasive mechanisms to parasite persistence in visceral leishmaniasis","volume":"7","author":"de Freitas","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phrs.2022.106117_bib87","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2613.2001.00199.x","article-title":"Tissue granuloma structure-function in experimental visceral leishmaniasis","volume":"82","author":"Murray","year":"2001","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.phrs.2022.106117_bib88","first-page":"209","article-title":"Targeting of liposomal andrographolide to L. donovani-infected macrophages in vivo","volume":"7","author":"Sinha","year":"2000","journal-title":"Drug Deliv. J. Deliv. Target. Ther. Agents"},{"key":"10.1016\/j.phrs.2022.106117_bib89","first-page":"169","article-title":"Delivery in vivo of 14-deoxy-11-oxoandrographolide, an antileishmanial agent, by different drug carriers","volume":"40","author":"Lala","year":"2003","journal-title":"Indian J. Biochem. Biophys."},{"key":"10.1016\/j.phrs.2022.106117_bib90","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/10611860500046732","article-title":"Targeted delivery of arjunglucoside I using surface hydrophilic and hydrophobic nanocarriers to combat experimental leishmaniasis","volume":"13","author":"Tyagi","year":"2005","journal-title":"J. Drug Target."},{"key":"10.1016\/j.phrs.2022.106117_bib91","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1128\/AAC.48.1.130-136.2004","article-title":"In vitro and in vivo activities of a triterpenoid saponin extract (PX-6518) from the plant Maesa balansae against visceral Leishmania species","volume":"48","author":"Maes","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phrs.2022.106117_bib92","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1128\/AAC.48.6.2056-2060.2004","article-title":"Comparative activities of the triterpene saponin maesabalide III and liposomal amphotericin B (AmBisome) against Leishmania donovani in hamsters","volume":"48","author":"Maes","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.phrs.2022.106117_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2022.106117_bib94","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.3390\/molecules200611219","article-title":"Topical anti-inflammatory activity of new hybrid molecules of terpenes and synthetic drugs","volume":"20","author":"Theoduloz","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2022.106117_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22030369","article-title":"Antiprotozoal activity of triazole derivatives of dehydroabietic acid and oleanolic acid","volume":"22","author":"Pertino","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2022.106117_bib96","first-page":"1271","article-title":"Activity of dihydroartemisinin against Leishmania donovani both in vitro and vivo","volume":"117","author":"Ma","year":"2004","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.phrs.2022.106117_bib97","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1590\/S0036-46652011000300003","article-title":"In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against Leishmania donovani in BALB\/c mice","volume":"53","author":"Mutiso","year":"2011","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"},{"key":"10.1016\/j.phrs.2022.106117_bib98","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1590\/S0074-02762012000300012","article-title":"In vitro evaluation of new terpenoid derivatives against Leishmania infantum and Leishmania braziliensis","volume":"107","author":"Ram\u00edrez-Mac\u00edas","year":"2012","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.phrs.2022.106117_bib99","doi-asserted-by":"crossref","first-page":"13003","DOI":"10.3390\/molecules181013003","article-title":"Biological activity of oleanane triterpene derivatives obtained by chemical derivatization","volume":"18","author":"Cheng","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2022.106117_bib100","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.ijbiomac.2017.04.098","article-title":"Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: development, characterization, in vitro and in vivo assessment for the therapy of leishmaniasis","volume":"102","author":"Das","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2022.106117_bib101","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.biopha.2017.11.026","article-title":"Nanotherapeutics: an insight into healthcare and multi-dimensional applications in medical sector of the modern world","volume":"97","author":"Prasad","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2022.106117_bib102","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.colsurfb.2015.04.013","article-title":"Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis","volume":"130","author":"Want","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.phrs.2022.106117_bib103","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822000627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822000627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:33:37Z","timestamp":1778582017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822000627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":103,"alternative-id":["S1043661822000627"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106117","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of terpenes in the treatment of visceral leishmaniasis: A systematic review of preclinical evidence","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106117"}}